Suzanne M. Garland

Research interests

Publications

• Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis

  The Lancet Infectious Diseases · 2020 · https://doi.org/10.1016/s1473-3099(20)30154-7

• Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30298-3

• Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

  Clinical Infectious Diseases · 2016 · https://doi.org/10.1093/cid/ciw354

• HPV-FASTER: broadening the scope for prevention of HPV-related cancer

  Nature Reviews Clinical Oncology · 2015 · https://doi.org/10.1038/nrclinonc.2015.146

• A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1405044

• Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

  The Lancet Infectious Diseases · 2014 · https://doi.org/10.1016/s1473-3099(14)70841-2

• Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease

  Cancer Epidemiology Biomarkers & Prevention · 2014 · https://doi.org/10.1158/1055-9965.epi-14-0410

• Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study

  PLoS ONE · 2013 · https://doi.org/10.1371/journal.pone.0079260

• Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70080-3

• A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

  Vaccine · 2012 · https://doi.org/10.1016/j.vaccine.2012.04.108

• Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

  The Journal of Infectious Diseases · 2012 · https://doi.org/10.1093/infdis/jis590

• Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

  The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70287-x

• Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

  The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70286-8

• Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

  JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djp534

• Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

  The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70230-8

• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

  The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)61248-4

• The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

  The Journal of Infectious Diseases · 2009 · https://doi.org/10.1086/597309

• The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

  The Journal of Infectious Diseases · 2009 · https://doi.org/10.1086/597307

• A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

  Cancer Prevention Research · 2009 · https://doi.org/10.1158/1940-6207.capr-09-0031

• Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

  New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa061760

• Etiologies of Nongonococcal Urethritis: Bacteria, Viruses, and the Association with Orogenital Exposure

  The Journal of Infectious Diseases · 2006 · https://doi.org/10.1086/499434

• High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence

  The Journal of Infectious Diseases · 2006 · https://doi.org/10.1086/503780

Current projects

No projects listed.